PPARG and polycystic ovary syndrome: The results of the present study revealed that AS-IV treatment noticeably up-regulated the protein levels of PPARγ in both the rat model of PCOS and in KGN cells, suggesting that AS-IV promotes PPARγ signaling in vitro and in vivo.